Chaitanya Divgi - Concepedia

Author

Chaitanya Divgi

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

C Divgi, C R DIVGI, C R Divgi, C. Divgi, C. R. Divgi, C.R. Divgi, Chaitanya Divgi, Chaitanya R Divgi, Chaitanya R. Divgi

196

Publications

8.2K

Citations

H-Index

113

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Pennsylvania Cornell University Columbia University Irving Medical Center Columbia University

About

Chaitanya Divgi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	3K
2	Health Sciences	16	18	1.5K
3	Engineering	5	5	120
4	Education	1	1	10
5	Nursing	1	1	276

Chaitanya Divgi

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Targeted α particle immunotherapy for myeloid leukemia Joseph G. Jurcic, Steven M. Larson, George Sgouros, Blood	2002	465
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial Chaitanya Divgi, Neeta Pandit‐Taskar, Achim A. Jungbluth, The Lancet Oncology Preoperative CharacterisationUrologySurgical OncologyOncologic ImagingGenitourinary Cancer	2007	383
Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung Carcinoma Chaitanya Divgi, S. Welt, Mark G. Kris, JNCI Journal of the National Cancer Institute Murine Monoclonal AntibodyMedicineImmunologyIndium 111Pathology	1991	300
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of <sup>211</sup>At-MX35 F(ab′)<sub>2</sub>—A Phase I Study Håkan Andersson, Elin Cederkrantz, Tom Bäck, Journal of Nuclear Medicine	2009	279
The SNMMI Practice Guideline for Therapy of Thyroid Disease with <sup>131</sup>I 3.0 Edward B. Silberstein, Abass Alavi, Helena Balon, Journal of Nuclear Medicine Snmmi Practice GuidelineUnited StatesRisk Levels……2 IvPerioperative SafetyPublic Health	2012	276
Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia Todd Rosenblat, Michael R. McDevitt, Deborah Mulford, Clinical Cancer Research	2010	260
Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial Chaitanya Divgi, Robert G. Uzzo, Constantine Gatsonis, Journal of Clinical Oncology	2012	251
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. David A. Scheinberg, Dennis Lovett, Chaitanya Divgi, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaImmunologyImmunotherapyAcute Myelogenous LeukemiaMyeloid Neoplasia	1991	227
Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. Neeta Pandit‐Taskar, Maria Batraki, Chaitanya Divgi PubMed Pain MedicineOsteoporosisOrthopaedic SurgeryBone DiseaseOncology	2004	225
Prolonged red cell storage before transfusion increases extravascular hemolysis Francesca Rapido, Gary M. Brittenham, Sheila Bandyopadhyay, Journal of Clinical Investigation	2016	197

Page 1